🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In August of 2014, the FDA approved ELELYSO for long-term enzyme replacemen...
Status
Withdrawn
Location
O&O Alpan LLC
Start Date
2019-07-31
Trial ID
NCT03021941
Treatments Being Tested
A protocol to extend the assessment of the safety and efficacy of taligluce...
Status
Completed
Location
Shaare Zedek Medical Center
Start Date
2011-09
Trial ID
NCT01411228
Treatments Being Tested
This is a multicenter study to assess the safety and efficacy of taliglucer...
Status
Completed
Location
All India Institute of Medical Sciences
Start Date
2020-11-20
Trial ID
NCT04002830
Treatments Being Tested
The objective of this study is to assess Elelyso treatment on bone disease ...
Status
Completed
Location
Multiple Locations
Start Date
2017-01-01
Trial ID
NCT04353466
Treatments Being Tested
This is a multi-center, open-label, switchover trial to assess the safety o...
Status
Completed
Location
University Research Foundation for Lysosomal Storage Diseases, Inc.
Start Date
2008-12
Trial ID
NCT00712348
Treatments Being Tested
Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Status
Completed
Location
Department of Human Genetics, Emory University School of Medicine
Start Date
2008-06
Trial ID
NCT00705939
Treatments Being Tested
Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00258778
Treatments Being Tested
This is a multi-center trial to further extend the assessment of the safety...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01422187
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of autolog...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT05815004
Treatments Being Tested
Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Status
Completed
Location
University Research Foundation for Lysosomal Storage Diseases
Start Date
2007-08
Trial ID
NCT00376168